Oncoproteins from DNA tumor viruses such as adenovirus E1a, simian virus 40
T antigen, and human papillomavirus E7 contain an LSCXE sequence, which th
ey use to bind the retinoblastoma protein (Rb) and inhibit its function. Ce
llular proteins such as histone deacetylases 1 and 2 (HDAC1 and -2) also co
ntain an LXCXE-like sequence, which they use to interact with Rb. The LXCXE
binding site in Rb was mutated to assess its role in Rb function. These mu
tations inhibited binding to HDAC1 and -3, which each contain an LXCXE-like
sequence, but had no effect on binding to HDAC3, which lacks an LXCXE-like
sequence. Mutation of the LXCXE binding site inhibited active transcriptio
nal repression by Rb and prevented it from effectively repressing the cycli
n E and A gene promoters. In contrast, mutations in the LXCXE binding site
did not prevent Rb from binding and inactivating E2F. Thus, the LXCXE mutat
ions appear to separate Rb's ability to bind and inactivate E2F from its ab
ility to efficiently recruit HDAC1 and -2 and actively repress transcriptio
n. In transient assays, several of the LXCXE binding site mutants caused an
increase in the percentage of cells in G(1) by flow cytometry, suggesting
that they can arrest cells, However, this effect was transient, as none of
the mutants affected cell proliferation in longer-term assays examining bro
modeoxyuridine incorporation or colony formation. Our results then suggest
that the LXCXE binding site is important for full Rb function. Mutation of
the LXCXE binding site does not inhibit binding of the BRG1 ATPase componen
t of the SWI/SNF nucleosome remodeling complex, which has been shown previo
usly to be important for Rb function. Indeed, overexpression of BRG1 and Rb
in cells deficient for the proteins led to stable growth inhibition, sugge
sting a cooperative role for SWI/SNF and the LXCXE binding site in efficien
t Rb function.